ParkinsonsDiseaseHelp

Research & Clinical Trials

Why an Alzheimer’s Drug Finding Cannot Automatically Be Applied to Parkinson’s Dementia

Learn why Alzheimer's amyloid drugs don't apply to Parkinson's dementia and what to ask your specialist.

Parkinson’s Research and the Difference Between Mild Cognitive Impairment and Dementia Outcomes

Learn how Parkinson's MCI differs from dementia, what raises risk, and when to get extra help.

What to Ask About Remote Cognitive Testing in a Parkinson’s Study

A practical list of questions to raise with study staff before a video, phone, or self-administered cognitive test in a Parkinson's trial.

Parkinson’s Dementia Studies and the Challenge of Recruiting Beyond Specialist Centers

Newer, broader studies are revising Parkinson's dementia risk estimates while exposing how much research still excludes patients outside specialist clinics.

What Happens During Screening for a Deep Brain Stimulation Trial?

A step-by-step look at the motor, cognitive, psychiatric, and imaging tests that decide DBS trial eligibility for Parkinson's patients.

How Movement Disorder Specialists Decide Which Trials to Recommend

A look at the eligibility checks, genetic testing, and risk comparisons specialists run before pointing a Parkinson's patient toward a trial.

What a Parkinson’s Caregiver Should Know Before a Study Visit Schedule

Study visit schedules can require caregiver attendance, formal burden assessments, and reimbursable travel — here's what to confirm before the first appointment.

How Levodopa Response Is Measured Before Enrolling in a Parkinson’s Trial

A step-by-step look at the OFF-to-ON levodopa challenge test trials use to decide who qualifies, including the thresholds and their known limits.

Can AI Improve Communication Between Parkinson’s Patients and Neurologists?

Trial data, patient surveys, and live tools like Ask PAM show where AI genuinely helps Parkinson's visits — and where it doesn't.

How Deep Brain Stimulation Candidates Are Chosen for Parkinson’s Trials

Why a strong levodopa response matters more to DBS eligibility than age, symptom severity, or how long someone has had Parkinson's.

How Parkinson’s Trials Account for Changes in Medication Timing

Learn how stable dosing, LEDD math, diaries, and timed clinic tests keep Parkinson's trial results honest.

Parkinson’s Research Participation When a Study Partner Cannot Drive

Learn how remote partner visits, travel support, and remote studies can keep enrollment open.

Why Parkinson’s Cognitive Trials May Use More Than One Thinking Test

See which thinking and daily-life tests Parkinson's trials use and how to get clearer test results.

Parkinson’s Dementia Research and the Need for Everyday Function Measures

See why daily-task ability defines Parkinson's dementia and how to track changes for care decisions.

Parkinson’s Research Headlines: Why a Promising Early Trial May Not Lead to Approval

Learn how to read Parkinson's trial headlines, spot early-stage limits, and ask sharper questions at your next visit.

Parkinson’s Trial Placebo Groups: What Care Do Participants Still Receive?

Learn what medicines, checkups and exit rights stay in place on placebo so you can join a trial with confidence.

Parkinson’s Clinical Trials: How to Tell Symptom Relief From Slower Disease Progression

See how trial design, OFF-drug scores and biomarkers separate lasting slowing from daily symptom ease.

Parkinson’s Biomarker Studies: Does Detecting a Protein Explain What Caused the Disease?

Learn what a positive synuclein test means for diagnosis, treatment talks, and trial options.

Parkinson’s Environmental Research: Why Exposure Timing May Matter as Much as Amount

Learn which life stages raise Parkinson's risk most and what exposure history to share with your doctor.

Genes and Pesticides in Parkinson’s Research: Can Both Contribute to Risk?

See how specific genes and farm pesticides interact in Parkinson's and steps to lower exposure risk.

1 2 3 Next »

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.